Healthcare Dive spoke with Evolent CEO Frank Williams to discuss why the shift to value-based care has been slow and on the difficulties of selling technology to providers. Of the questions asked, the publication touches on downside risk, the high cost of technology, and the challenges faced in the shift to value-based care.
Read: Evolent Health CEO Williams on Why the Road to Value-Based Care is Slow
Recent Posts
A Year in Review: A comprehensive look at UPMC Enterprises 2020
Over the last year, UPMC Enterprises, our portfolio companies, and select partners have all supported UPMC’s mission of Life Changing Medicine. In the booklet below, we have compiled highlights from a truly unique year and recognize the team members and projects that have enabled our success.
Read More →
Werewolf Therapeutics launches as publicly traded company
Werewolf Therapeutics, a biopharmaceutical company pioneering the development of therapeutics to stimulate the body’s immune …
Read More →
The Intersection of Value and AI: Where Machines Can Make a Difference
Upcoming CCM panel discussion features experts from UPMC, Vanderbilt, NCQA, and Astrata on the future of artificial intelligence in health care
Read More →